China Sanjiang Fine Chemicals Company Limited disclosed on 18 May 2026 that it repurchased 502,000 ordinary shares on 13 May 2026 through the Hong Kong Stock Exchange. The shares were purchased within a price range of HK$5.08–HK$5.17, with a volume-weighted average cost of HK$5.1033 per share, bringing the cash outlay to approximately HK$2.56 million.
The repurchased shares are slated for cancellation. Nevertheless, as of 13 May 2026, China Sanjiang’s issued share capital remains unchanged at 1.19 billion shares, with no treasury shares recorded on the balance sheet. Including the latest transaction, shares bought back under the current mandate total 3.502 million, representing 0.28 % of the company’s issued share base at the time the mandate was granted.
The buyback forms part of the authority approved on 30 May 2025, which permits the company to repurchase up to 119 million shares. Following the latest purchase, 115.50 million shares, or roughly 97 % of the mandate, remain available.
In line with Hong Kong listing requirements, the company is now subject to a moratorium on issuing new shares or disposing of treasury shares until 12 August 2026. The board affirms that all repurchases complied with the Main Board Listing Rules and relevant regulatory provisions.
Comments